■ 英語タイトル:Animal Drug Compounding Market (Product: Anti-infectives, Anti-inflammatory, CNS Agents, GI Drugs, and Others; and Route of Administration: Oral, Injectable, Topical, Rectal, and Ocular) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
|
 | ■ 発行会社/調査会社:Transparency Market Research
■ 商品コード:TMR23JN009
■ 発行日:2022年11月15日 ■ 調査対象地域:グローバル
■ 産業分野:医薬品
■ ページ数:233
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
|
■ 販売価格オプション
(消費税別)
Warning: foreach() argument must be of type array|object, null given in
/home/hni-mkt/globalresearch.co.jp/public_html/wp-content/themes/twentyfourteen/content.php on line
189
Warning: foreach() argument must be of type array|object, null given in
/home/hni-mkt/globalresearch.co.jp/public_html/wp-content/themes/twentyfourteen/content.php on line
193
Warning: foreach() argument must be of type array|object, null given in
/home/hni-mkt/globalresearch.co.jp/public_html/wp-content/themes/twentyfourteen/content.php on line
197
Warning: Undefined variable $YEN_USD in
/home/hni-mkt/globalresearch.co.jp/public_html/wp-content/themes/twentyfourteen/content.php on line
212
Warning: Undefined variable $YEN_USD in
/home/hni-mkt/globalresearch.co.jp/public_html/wp-content/themes/twentyfourteen/content.php on line
214
Warning: Undefined variable $YEN_USD in
/home/hni-mkt/globalresearch.co.jp/public_html/wp-content/themes/twentyfourteen/content.php on line
216
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
※Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
*** レポート概要(サマリー)***Transparency Market Research社の市場調査資料では、世界の動物用薬物調剤市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、製品別(抗感染薬、抗炎症薬、中枢神経作用薬、消化器官用薬、その他)分析、動物種類別(コンパニオン動物、家畜)分析、剤形別(カプセル、溶液、粉末、懸濁液、その他)分析、投与経路別(経口、注射剤、外用剤、直腸投与、接眼)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況など、以下の構成でのまとめています。さらに、本調査資料には、Wedgewood Pharmacy、Triangle Compounding Pharmacy、Davis Islands Pharmacy、Custom Med Compounding Pharmacy、Central Compounding Center South、Wellness Pharmacy of Cary、Caringbah Compounding Pharmacy、Millers Pharmacy, Smith's Pharmacy、Specialist Compounding Pharmacy Pte Ltd.、Tache Pharmacyなどの企業情報が記載されています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・主要インサイト
・世界の動物用薬物調剤市場規模:製品別
- 抗感染薬の市場規模
- 抗炎症薬の市場規模
- 中枢神経作用薬の市場規模
- 消化器官用薬の市場規模
- その他動物用薬物調剤の市場規模
・世界の動物用薬物調剤市場規模:動物種類別
- コンパニオン動物における市場規模
- 家畜における市場規模
・世界の動物用薬物調剤市場規模:剤形別
- カプセル状動物用薬物調剤の市場規模
- 溶液状動物用薬物調剤の市場規模
- 粉末状動物用薬物調剤の市場規模
- 懸濁液状動物用薬物調剤の市場規模
- その他動物用薬物調剤の市場規模
・世界の動物用薬物調剤市場規模:投与経路別
- 経口における市場規模
- 注射剤における市場規模
- 外用剤における市場規模
- 直腸投与における市場規模
- 接眼における市場規模
・世界の動物用薬物調剤市場規模:地域別
- 北米の動物用薬物調剤市場規模
- ヨーロッパの動物用薬物調剤市場規模
- アジア太平洋の動物用薬物調剤市場規模
- 中南米の動物用薬物調剤市場規模
- 中東・アフリカの動物用薬物調剤市場規模
・競争状況 |
Animal Drug Compounding Market – Scope of Report
TMR’s report on the global animal drug compounding market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global animal drug compounding market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global animal drug compounding market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the animal drug compounding market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global animal drug compounding market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global animal drug compounding market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global animal drug compounding market.
The report delves into the competitive landscape of the global animal drug compounding market. Key players operating in the global animal drug compounding market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global animal drug compounding market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market animal drug compounding.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
Animal Drug Compounding Market – Scope of Report
TMR’s report on the global animal drug compounding market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global animal drug compounding market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global animal drug compounding market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the animal drug compounding market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global animal drug compounding market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global animal drug compounding market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global animal drug compounding market.
The report delves into the competitive landscape of the global animal drug compounding market. Key players operating in the global animal drug compounding market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global animal drug compounding market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market animal drug compounding.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
*** 免責事項 ***https://www.globalresearch.co.jp/disclaimer/